Cercador
Ets a: Portada > Recerca > Ajuts a la recerca

Ajuts a la recerca

EFSD- Partnership for Diabetes Research in Europe

Organisme

The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.


Novo Nordisk is a global healthcare company with 88 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk has approximately 32,700 employees in 75 countries, and markets its products in 190 countries.
 

Objecte

 Programme Research and Focus : The EFSD/Novo Nordisk Partnership for Diabetes Research in Europe Programme will accept applications from all fields of diabetes research and including both basic and clinical research.

Sol·licitants

An application may be made by a principal investigator and up to two co-investigators. All principal investigators must be paid-up EASD members.

Requisits

Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review.

The deadline for receipt of research grant applications for funding is 1 February 2013.

All budgets are to be prepared in Euro. For countries in which the Euro is not yet the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification".

All applications must be prepared on the official forms and completed in strict accordance with the detailed instructions to be found on these forms. In particular, applicants are reminded that any pages in addition to the maximum of 10 allowed for the scientific section of the application will be deleted prior to review. Similarly, no applications using a font or line-spacing smaller than that defined in the instructions will be considered for review. Additional material (in the form of an appendix, attachment, reprints, etc.) is not acceptable and will not be sent to reviewers.
 

Descripció

Research will be supported through the award of grants of up to Euro 100,000 for basic research projects and Euro 400,000 for clinical research projects. The definition of clinical research is a study performed in human individuals and where there is a focus on a clinically relevant and diabetes-related outcome.

The duration of each award will depend upon the needs of the project and as justified in the application. EFSD may, at the suggestion of the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.

Applications with a funding requirement larger than that specified above may be considered; in this case, the total funding requirement should be indicated and justified in the budget section of the application. According to the duration and timetable of the project, funds will be made annually.

Applications for a grant through this Programme are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be normally employed at a non-profit institution and the study must be performed at their place of work.

Applications will be subject to a scientific review by a specialised and independent ad hoc committee. Funding will require approval by a Programme Board convened for this purpose, and will be awarded by May 2013.

Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserve the right to request revision to applications in accordance with the recommendations of the Review Committee.
 

Termini oficial

Deadline Date: 1 February 2013.

Important: Please send your application as one complete PDF e.mail attachment by 12:00 noon (CET) on the deadline date:

Termini IISPV

Cal comunicar abans del 15 de desembre de 2012 que es vol participar a la convocatòria, enviant un e-mail a convocatories@iispv.cat . Termini IISPV 14 01 2013

Enllaços relacionats

Pujar

Fes-ho córrer

  • Facebook
  • TwitThis
  • LinkedIn
  • eMail

IISPV

IISPVInstitut d'Investigació Sanitària Pere Virgili (IISPV)

Work Centre d'R+D+I en Nutrició i Salut
Avda. de la Universitat, 1 - 2a planta
E-43204 Reus (Tarragona)

Tel. Work977 75 93 94 http://www.iispv.cathttp://www.iispv.cat

Generalitat de Catalunya

Universitat Rovira i Virgili (URV)

ICS - Institut Català de la Salut

Hospital Universitari Sant Joan de Reus

Centre de Recerca de Catalunya

Universitat Excel·lència - Universitat Rovira i Virgili - Investigació excel·lència - Postgrau Excel·lència

HR Excellence in Research

Institut Pere Mata, Hospital Psiquiàtric Universitari

Twitter

Linkedin

Youtube

© IISPV, tots els drets reservats